Newsroom

Sorted by: Latest

-

Morris & Dickson LLC Signs Letter of Intent to Acquire Prodigy Health

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson, the nation’s largest independent wholesale and specialty distributor, today announced that it has signed a non-binding Letter of Intent (LOI) to acquire Prodigy Health, a privately held, national specialty distributor of plasma derivatives, specialty drugs and vaccines. The proposed acquisition underscores Morris & Dickson’s accelerated growth in serving both inpatient and outpatient care settings for health systems, hospitals and prov...
-

Un estudio revela que la IA no podrá transformar los sistemas de movilidad si la colaboración entre partes no sale de lo habitual

RIAD, Arabia Saudita--(BUSINESS WIRE)--La inteligencia artificial está transformando los sistemas de transporte globales de manera silenciosa, pero la mayoría de las implementaciones siguen siendo proyectos piloto aislados que no alcanzan escalas significativas, y se amplía la brecha entre las promesas de la IA y su puesta en marcha, según reveló un estudio representativo presentado hoy en CoMotion GLOBAL en Riad. El informe Envisioning the Future of Mobility Powered by AI (Pensar el futuro de...
-

emeis : Programme de rachat de titres

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) : Déclaration des transactions sur actions propres Période du 1 au 5 décembre 2025 Emetteur : EMEIS (LEI : 969500LHIH3NT7PK1V89) Catégories de titres : actions ordinaires (ISIN : FR001400NLM4) Descriptif du programme mis en ligne sur le site Internet de l’Autorité des Marchés Financiers le 8 décembre 2025 Rapport hebdomadaire sur les rachats d'actions du 3 novembre au 7 novembre 2025   Nom de l'émetteur Code identifiant de l...
-

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 12/8/2025 Issue ¦ Gracechurch Card Programme Funding PLC - Series 14 - 2 Class D GBP 286,793,000 FRN due June 2024     ISIN Number ¦ XS1133034253 ISIN Reference ¦ 113303425 Issue Nomin GBP ¦ 286793000 Period ¦ 11/17/2025 to 12/15/2025   Payment Date 12/15/2025 Number of Days ¦ 28 Rate ¦ 8.9757   Denomination GBP ¦ 1000   ¦ 286793000   ¦       Amount Payable per Denomination ¦ 6.89   ¦ 1974704.17   ¦...
-

MaaT Pharma présente les résultats de l’étude pivotale de Phase 3 ARES pour MaaT013 (Xervyteg®) dans la GvH aiguë au Congrès annuel de l’ASH 2025 et annonce 54% de Survie Globale à 1 an

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce aujourd’hui que le docteur Florent Malard, PhD et professeur d’hématologie à l’Hôpital Saint-Antoine et à Sorbonne Université, et investigateur principal de l’ess...
-

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages DeFi Technologies Inc. (DEFT) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DeFi Technologies Inc. (“DeFi” or the “Company”) (NASDAQ: DEFT) securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). DeFi investors have until January 30, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR D...
-

Milliman Announces Acquisition of MorVest Capital, Expanding Leadership in Mortgage Sector and MSR Analytics

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a leading global consulting and actuarial firm, today announced the acquisition of MorVest Capital, a premier provider of mortgage servicing rights (MSR) analytics, risk management, and advisory services. This strategic move reinforces Milliman’s commitment to delivering comprehensive analytical solutions to the mortgage sector and expands its capabilities with MSR valuation, financing, hedging, and brokering. MorVest Capital, founded in 2013 and headqu...
-

MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival

LYON, France--(BUSINESS WIRE)--MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival....
-

SERHANT. and T-Mobile Join Forces to Turbocharge S.MPLE’s AI Engine and Transform Agent Mobile Productivity with SuperMobile

NEW YORK--(BUSINESS WIRE)--SERHANT., the mobile-first real estate brokerage and media company, today announced a first-of-its-kind collaboration with T-Mobile to bring SuperMobile to the firm. SuperMobile strengthens the connectivity agents rely on to power S.MPLE — SERHANT.’s proprietary AI platform — and other essential mobile tasks. With intelligent performance, built-in security, and satellite-to-cell coverage, SuperMobile provides a level of connectivity no other provider offers to profess...
-

Legrand: Statement of Transactions in Own Shares From 01/12/2025 to 03/12/2025

LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR): Aggregated presentation by day and by market   Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares* Market (MIC Code) LEGRAND SA 969500XXRPGD7HCAFA90 1-Dec-25 FR0010307819 30 835 128,9506 XPAR LEGRAND SA 969500XXRPGD7HCAFA90 2-Dec-25 FR0010307819 26 213 128,9530 XPAR LEGRAND...